| Mr Haitham A Elconsul, MD | |
|
1800 W Charleston Blvd, Las Vegas, NV 89102-2329 | |
| (702) 671-2345 | |
| (702) 671-2376 |
| Full Name | Mr Haitham A Elconsul |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 24 Years |
| Location | 1800 W Charleston Blvd, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609038363 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 13932 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rabessler Md Pc | 6709978562 | 21 |
| Ahmad Noman Md Pc | 7517082977 | 5 |
News Archive
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy.
To secure a state-of-the-art education for tomorrow's nurses, Maryland's nurse educators must become masters of simulation technology. Faculty from 10 Maryland nursing schools have now learned how to incorporate simulation training in their teaching thanks to the Maryland Faculty Academy for Simulation Teaching in Nursing (M-FAST), held on January 9-13, 2012 at the Johns Hopkins University School of Nursing.
Researchers at the University of Pittsburgh have identified how a single aberrant cell can duplicate to form cancerous tumors, suggesting a specific protein mechanism as a target for the treatment of cancer, they report in a paper titled "Spindle Multipolarity Is Prevented by Centrosomal Clustering," published in the Jan. 7 issue of Science.
Sanofi Pasteur announced today it has received the new influenza A(H1N1) seed virus, enabling the world's leading manufacturer of influenza vaccines to begin the production process for an A(H1N1) vaccine.
› Verified 1 days ago
| Entity Name | Rabessler Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174731970 PECOS PAC ID: 6709978562 Enrollment ID: O20070823001024 |
News Archive
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy.
To secure a state-of-the-art education for tomorrow's nurses, Maryland's nurse educators must become masters of simulation technology. Faculty from 10 Maryland nursing schools have now learned how to incorporate simulation training in their teaching thanks to the Maryland Faculty Academy for Simulation Teaching in Nursing (M-FAST), held on January 9-13, 2012 at the Johns Hopkins University School of Nursing.
Researchers at the University of Pittsburgh have identified how a single aberrant cell can duplicate to form cancerous tumors, suggesting a specific protein mechanism as a target for the treatment of cancer, they report in a paper titled "Spindle Multipolarity Is Prevented by Centrosomal Clustering," published in the Jan. 7 issue of Science.
Sanofi Pasteur announced today it has received the new influenza A(H1N1) seed virus, enabling the world's leading manufacturer of influenza vaccines to begin the production process for an A(H1N1) vaccine.
› Verified 1 days ago
| Entity Name | Ahmad Noman Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750609871 PECOS PAC ID: 7517082977 Enrollment ID: O20100909000379 |
News Archive
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy.
To secure a state-of-the-art education for tomorrow's nurses, Maryland's nurse educators must become masters of simulation technology. Faculty from 10 Maryland nursing schools have now learned how to incorporate simulation training in their teaching thanks to the Maryland Faculty Academy for Simulation Teaching in Nursing (M-FAST), held on January 9-13, 2012 at the Johns Hopkins University School of Nursing.
Researchers at the University of Pittsburgh have identified how a single aberrant cell can duplicate to form cancerous tumors, suggesting a specific protein mechanism as a target for the treatment of cancer, they report in a paper titled "Spindle Multipolarity Is Prevented by Centrosomal Clustering," published in the Jan. 7 issue of Science.
Sanofi Pasteur announced today it has received the new influenza A(H1N1) seed virus, enabling the world's leading manufacturer of influenza vaccines to begin the production process for an A(H1N1) vaccine.
› Verified 1 days ago
| Entity Name | Bessler Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801288774 PECOS PAC ID: 1355660077 Enrollment ID: O20150430002704 |
News Archive
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy.
To secure a state-of-the-art education for tomorrow's nurses, Maryland's nurse educators must become masters of simulation technology. Faculty from 10 Maryland nursing schools have now learned how to incorporate simulation training in their teaching thanks to the Maryland Faculty Academy for Simulation Teaching in Nursing (M-FAST), held on January 9-13, 2012 at the Johns Hopkins University School of Nursing.
Researchers at the University of Pittsburgh have identified how a single aberrant cell can duplicate to form cancerous tumors, suggesting a specific protein mechanism as a target for the treatment of cancer, they report in a paper titled "Spindle Multipolarity Is Prevented by Centrosomal Clustering," published in the Jan. 7 issue of Science.
Sanofi Pasteur announced today it has received the new influenza A(H1N1) seed virus, enabling the world's leading manufacturer of influenza vaccines to begin the production process for an A(H1N1) vaccine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Haitham A Elconsul, MD 1701 W Charleston Blvd, #215, Las Vegas, NV 89102-2325 Ph: (702) 671-2355 | Mr Haitham A Elconsul, MD 1800 W Charleston Blvd, Las Vegas, NV 89102-2329 Ph: (702) 671-2345 |
News Archive
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy.
To secure a state-of-the-art education for tomorrow's nurses, Maryland's nurse educators must become masters of simulation technology. Faculty from 10 Maryland nursing schools have now learned how to incorporate simulation training in their teaching thanks to the Maryland Faculty Academy for Simulation Teaching in Nursing (M-FAST), held on January 9-13, 2012 at the Johns Hopkins University School of Nursing.
Researchers at the University of Pittsburgh have identified how a single aberrant cell can duplicate to form cancerous tumors, suggesting a specific protein mechanism as a target for the treatment of cancer, they report in a paper titled "Spindle Multipolarity Is Prevented by Centrosomal Clustering," published in the Jan. 7 issue of Science.
Sanofi Pasteur announced today it has received the new influenza A(H1N1) seed virus, enabling the world's leading manufacturer of influenza vaccines to begin the production process for an A(H1N1) vaccine.
› Verified 1 days ago
Dr. Vinod Korrapati, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 2720 N Tenaya Way, Las Vegas, NV 89128 Phone: 419-865-3040 Fax: 702-560-2928 | |
Juan Esteban Rey Rueda, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3540 W Sahara Ave # 330, Las Vegas, NV 89102 Phone: 725-217-8555 Fax: 702-259-1252 | |
Miss Nasibo Hassan Kadir, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8280 W Warm Springs Rd, Las Vegas, NV 89113 Phone: 702-492-8592 Fax: 702-492-8045 | |
Nicholas Kalayeh, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 4275 Burnham Ave, Ste 220, Las Vegas, NV 89119 Phone: 702-796-4278 Fax: 702-737-9286 | |
Mir A Majeed, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 8280 W Warm Springs Rd, Las Vegas, NV 89113 Phone: 702-921-6829 Fax: 702-921-6828 | |
Dr. Monsuru O Ibraheem, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6970 W. Patrick Lane, Suite 140, Las Vegas, NV 89113 Phone: 702-450-1717 Fax: 702-947-6740 | |
Sameer Tapryal, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 S Rainbow Blvd, Hcpnv Inpatient Team, Las Vegas, NV 89145 Phone: 702-952-9171 Fax: 702-952-9136 |